Clinical Trial Update: Metformin and Simvastatin Use in Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating metformin and simvastatin for bladder cancer. Current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• metformin (metformin)

Snippet

Sponsor: London Health Sciences Centre | Conditions: Bladder Cancer | Phase 2 | Status: UNKNOWN